Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1555, 2006-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Inadvertent cardiovascular risk following rofecoxib initiation
Reactions Weekly, Vol. 1, Iss. 1067, 2005-01 ,pp. :
Celecoxib associated with similar cardiovascular risk to rofecoxib
Reactions Weekly, Vol. 1, Iss. 1048, 2005-01 ,pp. :
Increased risk of cardiovascular death with azithromycin
Reactions Weekly, Vol. 1, Iss. 1403, 2012-01 ,pp. :
Cardiovascular risk factors in progressive renal disease
By Harris KPG
Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. :